MP57-19 TIM-3 AND TIGIT ARE POTENTIAL IMMUNE CHECKPOINT TARGETS IN PATIENTS WITH BLADDER CANCER

John P. Sfakianos,Adam M. Farkas,Jorge Daza,Harry Anastos,Matthew D. Galsky,Nina Bhardwaj

MP57-19 TIM-3 AND TIGIT ARE POTENTIAL IMMUNE CHECKPOINT TARGETS IN PATIENTS WITH BLADDER CANCER

2019

John P. Sfakianos
Adam M. Farkas
Jorge Daza
Harry Anastos
Matthew D. Galsky
Nina Bhardwaj

INTRODUCTION AND OBJECTIVES:The introduction of immune checkpoint inhibition with PD-1/PDL-1 blockade represents a paradigm shift in the clinical management of patients with bladder cancer (BCa). H...

Keywords:

Pathology
Cancer research
Immune checkpoint
Bladder cancer
TIGIT
Medicine
in patient
Urology
Blockade

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations